Från professionella översättare, företag, webbsidor och fritt tillgängliga översättningsdatabaser.
devedeset bolesnika randomiziranih na placebo + br prešlo je na uzimanje lijeka imbruvica nakon što je nezavisno irc potvrdio progresiju.
ninety patients randomised to placebo + br crossed over to receive imbruvica following irc confirmed progression.
posreæi li mu se te je naðe, zaista, kaem vam, raduje se zbog nje vie nego zbog onih devedeset i devet koje nisu zalutale.
and if so be that he find it, verily i say unto you, he rejoiceth more of that sheep, than of the ninety and nine which went not astray.
sto devedeset bolesnika je imalo procjenjiv odgovor u barem jednoj vremenskoj točki i bili su uključeni u analizu (tablica 3).
one hundred and ninety had at least 1 evaluable time point response and were included in the analysis (table 3).
devedeset i šest posto bolesnika na monoterapiji dabrafenibom u integriranoj populaciji u kojoj se ispitivala sigurnost i svi bolesnici na kombiniranoj terapiji u ispitivanjima faze iii u kojih se razvio cuscc nastavilo je primati terapiju bez prilagodbe doze.
ninety-six percent of patients on dabrafenib monotherapy in the integrated safety population and all patients on combination therapy in the phase iii studies who developed cuscc continued on treatment without dose modification.
devedeset šest (96) sati nakon primjene foscana, mjesto liječenja obasjava se svjetlošću valne duljine od 652 nm iz odobrenog laserskog izvora.
96 hours after the administration of foscan, the treatment site is to be illuminated with light at 652 nm from an approved laser source.
devedeset i devet posto ispitanika (243/246) uključenih u sts ispitivanje faze iii, uključujući 15 ispitanika, primalo je antracikline.
99 % of patients (243/246) enrolled in the sts phase iii study, including the 15 subjects, received anthracycline.
devedeset i sedam posto bolesnika koji su završili randomizirana ispitivanja u bolesnika s parcijalnim napadajima bilo je uključeno u otvoreni produžetak ispitivanja (n=1186).
ninety-seven percent of the patients who completed the randomised trials in patients with partial onset seizures were enrolled in the open label extension study (n=1186).